← Leaderboards
Brian Green
Vulcan Biologics, Inc.
$299,914
Attributed
$299,914
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$299,914 · 1
By mechanism
N43$299,914 · 1
Top collaborators
No co-investigators on record.
Most similar at Vulcan Biologics, Inc.
Same institution · by research overlap
- Michael Koeris$1,234,854
Others in their field
Other Rising Stars on “Antibiotic Resistance”
- Andrew Tomaras · Forge Therapeutics, Inc.$10,977,909
- Urs Oschner · Crestone, Inc.$8,499,692
- Brian Kane · Spero Therapeutics, Inc.$6,712,318
- M.r.k. (dickon) Alley · An2 Therapeutics, Inc.$4,957,446
- Ralf Lenigk · Ge Medical Systems Information Technologies, Inc$4,211,973
- Laurene Wang · Aimmax Therapeutics, Inc.$3,663,308
Research focus
Antibiotic ResistanceAntibioticsBacteriophagesDesignGenus MycobacteriumImmune ResponseMycobacterialMycobacterium InfectionsNon-Tuberculous Mycobacterial InfectionPre-ClinicalPreclinical DevelopmentPre-Clinical ResearchPropertyResistanceRouteSmall Business Innovation Research GrantTechnologyTherapeutic DevelopmentVariant